Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-05-16

Clinical Trial Update: Sphenopalatine Block Versus BOTOX in Management of Chronic Migraine [NA]

View source ↗

Summary

Clinical trial comparing sphenopalatine block versus BOTOX for chronic migraine; the study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Botox (OnabotulinumtoxinA)
  • Sphenopalatine Block

Snippet

Sponsor: Cairo University | Conditions: Sphenopalatine Block, BOTOX | NA | Status: RECRUITING